In Brief: APhA
This article was originally published in The Tan Sheet
Executive Summary
APhA: Names Calvin Knowlton, PhD, a research associate at Philadelphia College of Pharmacy & Science, as president following the resignation of Robert Davis on May 24 due to a perceived conflict of interest. Davis is a senior VP at FoxMeyer and the president of OmNex Health, the FoxMeyer information management subsidiary formerly known as HealthConnect. OmNex recently acquired Pharmaceutical Care Services, a provider of pharmaceutical care retraining for pharmacists and pharmacy owners...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
People In Brief
Perrigo promotes in pricing, planning
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: